Ftse Mib
34.249,77
0,91%
DAX
18.161,01
1,32%
S&P 500
5.109,00
1,20%
NASDAQ Composite
15.927,76
2,02%
Bitcoin
63.967,70
-0,80%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Assistenza
Home Investire Azioni Europa EU OSE Immunotherapeutics (OSE) OSE Immunotherapeutics (OSE) Notizie

OSE Immunotherapeutics

OSE
5,56
-0,04 (-0,71%)
26 Apr 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: Euronext
Tipo: Azione Ordinaria
Valuta: EUR

Ultime notizie

Data Ora Fonte Titolo
16/4/202418:00GLOBEOSE Immunotherapeutics’ Global License to Develop a Novel..
10/4/202418:00GLOBEOSE Immunotherapeutics reçoit un financement public de 8,4..
03/4/202418:00GLOBEInformations relatives au nombre total de droits de vote et..
02/4/202407:30GLOBEOSE Immunotherapeutics annonce une publication sur CLEC-1,..
27/3/202418:00GLOBEOSE Immunotherapeutics publie ses résultats financiers..
18/3/202407:30BWOSE Immunotherapeutics annonce la fin du recrutement dans..
01/3/202418:00BWOSE Immunotherapeutics : Informations relatives au nombre..
28/2/202407:45BWOSE Immunotherapeutics to Host a Live Webcast to Discuss..
28/2/202407:30BWAbbVie et OSE Immunotherapeutics annoncent un partenariat..
26/2/202418:00BWOSE Immunotherapeutics Provides Update on Clinical Results..
02/2/202418:00BWOSE Immunotherapeutics : Informations relatives au nombre..
19/1/202407:30BWOSE Immunotherapeutics Highlights Clinical Portfolio..
05/1/202418:00BWOSE Immunotherapeutics : Informations relatives au nombre..
11/12/202307:30BWOSE Immunotherapeutics and Nantes University Hospital..
05/12/202318:00BWOSE Immunotherapeutics : Informations relatives au nombre..
21/11/202318:00BWOSE Immunotherapeutics Announces a Collaboration Agreement..
06/11/202318:00BWOSE Immunotherapeutics : Informations relatives au nombre..
23/10/202318:00BWOSE Immunotherapeutics Announces First Clinical Results for..
16/10/202307:30BWOSE Immunotherapeutics Presents First Positive Clinical..
05/10/202318:00BWOSE Immunotherapeutics : Informations relatives au nombre..
27/9/202318:03BWOSE Immunotherapeutics Announces H1 2023 Results and..
20/9/202307:30BWOSE Immunotherapeutics Updates on its Research Programs in..
11/9/202318:00BWOSE Immunotherapeutics Announces: Positive Phase 3 Data from..
04/9/202318:00BWOSE Immunotherapeutics : Informations relatives au nombre..
01/8/202307:30BWOSE Immunotherapeutics annonce une nouvelle aide publique..
19/7/202318:00BWOSE Immunotherapeutics annonce une publication sur OSE-230,..
11/7/202318:00BWOSE Immunotherapeutics and Nantes University Hospital..
10/7/202318:00BWOSE Immunotherapeutics : Informations relatives au nombre..
06/7/202307:30BWOSE Immunotherapeutics Announces for Lusvertikimab, its..
04/7/202318:00BWOSE Immunotherapeutics Announces New US Patent Granted for..
22/6/202318:00BWOSE Immunotherapeutics Reports on its 2023 Combined General..
20/6/202318:00BWOSE Immunotherapeutics reçoit un financement de 1,5 M€ de..
15/6/202307:30BWOSE Immunotherapeutics Presents Update on BiCKI®IL-7, CLEC-1..
12/6/202318:00BWOSE Immunotherapeutics : Informations relatives au nombre..
06/6/202307:30BWOSE Immunotherapeutics présente des abstracts cliniques sur..
01/6/202318:00BWOSE Immunotherapeutics SA : Mise à disposition des documents..
31/5/202318:00BWOSE Immunotherapeutics’ Board of Directors Proposes the..
12/5/202318:15BWOSE Immunotherapeutics : Informations relatives au nombre..
12/5/202318:00BWOSE Immunotherapeutics to Continue the Clinical Development..
02/5/202318:00BWOSE Immunotherapeutics SA : Mise à disposition du Document..
27/4/202318:00BWOSE Immunotherapeutics Reports Full Year 2022 Financial..
Apertura: 5,57 Min: 5,52 Max: 5,73
Chiusura: 5,60

La tua Cronologia

EU
OSE
OSE Immunotherapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network